AU2683792A - Peptide based hepatitis c virus immunoassays - Google Patents

Peptide based hepatitis c virus immunoassays

Info

Publication number
AU2683792A
AU2683792A AU26837/92A AU2683792A AU2683792A AU 2683792 A AU2683792 A AU 2683792A AU 26837/92 A AU26837/92 A AU 26837/92A AU 2683792 A AU2683792 A AU 2683792A AU 2683792 A AU2683792 A AU 2683792A
Authority
AU
Australia
Prior art keywords
immunoassays
virus
peptide based
based hepatitis
hepatitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26837/92A
Inventor
Kenneth H. Burk
Gordon R. Dreesman
Daniel Pauletti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genelabs Technologies Inc
Original Assignee
Genelabs Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genelabs Technologies Inc filed Critical Genelabs Technologies Inc
Publication of AU2683792A publication Critical patent/AU2683792A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU26837/92A 1991-09-16 1992-09-16 Peptide based hepatitis c virus immunoassays Abandoned AU2683792A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US76213591A 1991-09-16 1991-09-16
US762135 1991-09-16
US83571792A 1992-02-12 1992-02-12
US835717 1992-02-12

Publications (1)

Publication Number Publication Date
AU2683792A true AU2683792A (en) 1993-04-27

Family

ID=27117081

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26837/92A Abandoned AU2683792A (en) 1991-09-16 1992-09-16 Peptide based hepatitis c virus immunoassays

Country Status (2)

Country Link
AU (1) AU2683792A (en)
WO (1) WO1993006488A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9105871D0 (en) * 1991-03-20 1991-05-08 Inst Cientifico Tecnol Navarra Synthetic peptides
WO1994024565A1 (en) * 1993-04-22 1994-10-27 Genelabs Technologies, Inc. Hepatitis c virus immunodiagnostic antigens and antibodies
IT1270941B (en) * 1993-05-12 1997-05-26 Sorin Biomedica Spa HCV PEPTIDES AND THEIR USES.
AU6913394A (en) * 1993-05-13 1994-12-12 United States Of America, As Represented By The Secretary, Department Of Health And Human Services Nucleic acid tagged immunoassay
JP3217600B2 (en) * 1994-07-12 2001-10-09 株式会社先端生命科学研究所 Immunoassay for non-A non-B hepatitis virus-related antigen, monoclonal antibody used therein, and hybridoma producing this antibody
CN1114106C (en) * 1994-07-25 2003-07-09 罗切诊断学有限公司 Peptides marked with metal chelates
ES2174957T5 (en) * 1994-07-29 2006-12-16 Innogenetics N.V. PURIFIED PROTEINS OF HEPATITIS C VIRUS WRAPPING FOR DIAGNOSTIC AND THERAPEUTIC USE.
US5670310A (en) * 1994-07-29 1997-09-23 The United States Of America As Represented By The Department Of Health And Human Services Methods and compositions for differential diagnosis of acute and chronic hepatitis c virus infection
KR19990008122A (en) * 1995-04-28 1999-01-25 곤도도시유키 Antigen Peptide Compounds and Immunological Assays
AU752131C (en) * 1997-11-06 2003-12-04 Innogenetics N.V. Multi-mer peptides derived from hepatitis C virus envelope proteins for diagnostic use and vaccination purposes
WO1999062945A2 (en) * 1998-06-05 1999-12-09 Peptide Solutions, Inc. Peptide antigens for detection of hiv, hcv and other microbial infections
US6815160B1 (en) 1999-07-28 2004-11-09 Chiron Corporation Hepatitis C viral antigen immunoassay detection systems
JP5498637B2 (en) * 1999-07-28 2014-05-21 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド Hepatitis C virus antigen immunoassay detection system

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2656995B2 (en) * 1989-03-17 1997-09-24 カイロン コーポレイション NANBV diagnostics
KR940000755B1 (en) * 1990-02-16 1994-01-29 유나이티드 바이오메디칼 인코오포레이티드 Synthetic peptides specific for the detection of antibodies to hcv

Also Published As

Publication number Publication date
WO1993006488A1 (en) 1993-04-01

Similar Documents

Publication Publication Date Title
AU2371692A (en) Recombinant hepatitis a virus vaccine
AU2064297A (en) Hepatitis c virus ribozymes
IL102964A0 (en) Hla-restricted hepatitis b virus ctl epitopes
AU4450093A (en) Hepatitis A virus vaccine
AU2683792A (en) Peptide based hepatitis c virus immunoassays
EP0747482A3 (en) Hepatitis GB virus recombinant proteins and uses thereof
AU5679394A (en) Hepatitis b virus vaccines
AU3509693A (en) A recombinant hepatitis C virus polypeptide
AU2370592A (en) Epitopes of the env protein of the hepatitis c virus
EP0586065A3 (en) Antigenic peptides for grouping hepatitis c virus, kit comprising the same and methods for its grouping using the same
AU1522792A (en) Multiple hepatitis b virus surface proteins which form particles
AU688259B2 (en) Hepatitis C virus peptides
AU2068992A (en) Non-a, non-b peptide
AU7679491A (en) Hepatitis c virus protease inhibitors
AU2347692A (en) Recombinant viral vaccine
AU3084792A (en) Non-a, non-b peptides
AU1346092A (en) Angiogenic peptides
AU4399197A (en) Hepatitis c virus epitope
AU2623392A (en) Non-a, non-b peptides
EP0580758A4 (en) Anti-human immunodeficiency virus recombinant antibodies.
ZA926441B (en) HLA-restricted hepatitis B virus CTL epitopes.
AU1198192A (en) Novel peptide
GB9124696D0 (en) Hepatitis c virus
GB9106568D0 (en) Recombinant antigen
GB9220010D0 (en) Recombinant virus